project id: TCGA-UCEC; case submitter id: TCGA-AX-A3FW; source center: 23; state: released; a260 a280 ratio: 1.89; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.0; rna integrity number: 8.7; age at index: 66; days to birth: -24419; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Alive; year of birth: 1943; age at diagnosis: 24419; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 17.0; figo stage: Stage IB; icd 10 code: C54.1; last known disease status: not reported; morphology: 8380/3; primary diagnosis: Endometrioid adenocarcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Endometrium; synchronous malignancy: No; tissue or organ of origin: Endometrium; tumor grade: Not Reported; year of diagnosis: 2009; treatment or therapy: not reported; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 723; initial weight: 90.0; oct embedded: false; preservation method: Unknown; sample id: d3deb563-5420-4890-b763-01ca855b4b61; sample submitter id: TCGA-AX-A3FW-01A; portion id: d509477d-a220-4470-a7d9-f82f12d64238; portion submitter id: TCGA-AX-A3FW-01A-11; slide id: d08631c4-0f25-42e5-a0d5-ac2003c49207; slide submitter id: TCGA-AX-A3FW-01A-01-TS1; percent lymphocyte infiltration: 2.0; percent monocyte infiltration: 1.0; percent necrosis: 2.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 2.0; percent tumor cells: 96.0; percent tumor nuclei: 95.0; section location: TOP;